Rational design of nonnatural peptides as high-affinity ligands for the HLA-B*2705 human leukocyte antigen
about
New synthetic non-peptide ligands for classical major histocompatibility complex class I molecules.Changes at the floor of the peptide-binding groove induce a strong preference for proline at position 3 of the bound peptide: molecular dynamics simulations of HLA-A*0217.T-cell epitope prediction and immune complex simulation using molecular dynamics: state of the art and persisting challenges.Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathiesAntigenic peptides containing large PEG loops designed to extend out of the HLA-A2 binding site form stable complexes with class I major histocompatibility complex molecules.Immunoinformatics and modeling perspective of T cell epitope-based cancer immunotherapy: a holistic picture.Peptidomimetics: modifying peptides in the pursuit of better vaccines.Binding of rationally designed non-natural peptides to the human leukocyte antigen HLA-B*2705.On the terminal homologation of physiologically active peptides as a means of increasing stability in human serum--neurotensin, opiorphin, B27-KK10 epitope, NPY.A structure-based approach to designing non-natural peptides that can activate anti-melanoma cytotoxic T cells.Peptide binding by class I and class II MHC molecules.Substituting nonpeptidic spacers for the T cell receptor-binding part of class I major histocompatibility complex-binding peptides.
P2860
Q31993493-4F1D8AA9-F93D-4612-B851-CA24171BE6BEQ33913099-BF4967EE-C861-434F-9703-068074B5B101Q34312495-867D13AA-965C-42B9-A58E-5A0A105BFCBFQ37362148-6B051F2B-72A3-47AB-BC64-567E10A6D9BDQ37598071-BA9DD9E0-6C79-4B04-9E34-61B30A604191Q37606469-5BA3F57F-F657-46F3-B92F-C679F9714946Q37844539-89A5652B-E52B-4F8A-90D0-FE4E65D6D71CQ38331811-D3156BEF-9A02-4F84-8B4C-8D69C3AC9529Q39544807-F21CAA85-2975-4B22-8B95-617E04CC3912Q40963061-76FD1D7A-F781-496E-8C70-1CC43C07AA88Q41605278-6768C6A2-F5E8-4175-9D89-8136AAA440CEQ47828186-67FA7FFB-BF8B-4CFF-9020-470F7B3F2DB9
P2860
Rational design of nonnatural peptides as high-affinity ligands for the HLA-B*2705 human leukocyte antigen
description
1995 nî lūn-bûn
@nan
1995 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Rational design of nonnatural ...... B*2705 human leukocyte antigen
@ast
Rational design of nonnatural ...... B*2705 human leukocyte antigen
@en
Rational design of nonnatural ...... B*2705 human leukocyte antigen
@nl
type
label
Rational design of nonnatural ...... B*2705 human leukocyte antigen
@ast
Rational design of nonnatural ...... B*2705 human leukocyte antigen
@en
Rational design of nonnatural ...... B*2705 human leukocyte antigen
@nl
prefLabel
Rational design of nonnatural ...... B*2705 human leukocyte antigen
@ast
Rational design of nonnatural ...... B*2705 human leukocyte antigen
@en
Rational design of nonnatural ...... B*2705 human leukocyte antigen
@nl
P2093
P2860
P356
P1476
Rational design of nonnatural ...... B*2705 human leukocyte antigen
@en
P2093
P2860
P304
P356
10.1073/PNAS.92.3.753
P407
P577
1995-01-01T00:00:00Z